Quince Therapeutics, Inc. (QNCX) — SC 13G/A Filings
All SC 13G/A filings from Quince Therapeutics, Inc.. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (4)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Aug 6, 2024
- SC 13G/A Filing — Feb 14, 2024
-
BML Investment Partners Amends 13G/A on Quince Therapeutics (QNCX)
— Feb 7, 2024
BML Investment Partners, L.P. filed an amended Schedule 13G/A on February 7, 2024, indicating their ownership of Quince Therapeutics, Inc. (QNCX) common stock a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX